Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity ...

Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...

As new treatments emerge, timely diagnosis helps match patients with the most appropriate care when it can have the greatest ...

The American Academy of Neurology (AAN) has issued a position statement on therapies for neurological conditions that have ...

The FDA’s regular communications based on reports from its drug safety report database don’t always rattle investors’ cages. | In a quarterly update, the FDA said it’s evaluating the need for ...

An autopsy study of a 45-year-old former U.S. Navy crewman with severe chronic traumatic encephalopathy (CTE) suggested that ...

The American Academy of Neurology issues new guidelines to help clinicians navigate the use of unproven neurologic therapies lacking FDA approval or strong evidence.

Living in disadvantaged neighborhoods may increase the risk of Alzheimer’s disease by elevating biomarkers associated with inflammation and neurodegeneration.

Recurrent headaches are the number-one cause of disability of people under age 50, but remain under-diagnosed.

To help neurologists, clinicians and families understand the current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec, the American Academy of ...